318 related articles for article (PubMed ID: 35818559)
1. Cardiometabolic Comorbidities in Cancer Survivors:
Zullig LL; Sung AD; Khouri MG; Jazowski S; Shah NP; Sitlinger A; Blalock DV; Whitney C; Kikuchi R; Bosworth HB; Crowley MJ; Goldstein KM; Klem I; Oeffinger KC; Dent S
JACC CardioOncol; 2022 Jun; 4(2):149-165. PubMed ID: 35818559
[TBL] [Abstract][Full Text] [Related]
2. Modifiable Cardiometabolic Risk Factors in Survivors of Childhood Cancer:
Hammoud RA; Mulrooney DA; Rhea IB; Yu C; Johnson JN; Chow EJ; Ehrhardt MJ; Hudson MM; Ness KK; Armstrong GT; Dixon SB
JACC CardioOncol; 2024 Feb; 6(1):16-32. PubMed ID: 38510292
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in cancer survivors.
Okwuosa TM; Anzevino S; Rao R
Postgrad Med J; 2017 Feb; 93(1096):82-90. PubMed ID: 28123076
[TBL] [Abstract][Full Text] [Related]
4. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
[TBL] [Abstract][Full Text] [Related]
6. Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities:
Wilson RL; Christopher CN; Yang EH; Barac A; Adams SC; Scott JM; Dieli-Conwright CM
JACC CardioOncol; 2023 Oct; 5(5):553-569. PubMed ID: 37969654
[TBL] [Abstract][Full Text] [Related]
7. Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial.
Zullig LL; Shahsahebi M; Neely B; Hyslop T; Avecilla RAV; Griffin BM; Clayton-Stiglbauer K; Coles T; Owen L; Reeve BB; Shah K; Shelby RA; Sutton L; Dinan MA; Zafar SY; Shah NP; Dent S; Oeffinger KC
BMC Fam Pract; 2021 Nov; 22(1):234. PubMed ID: 34794388
[TBL] [Abstract][Full Text] [Related]
8. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
[TBL] [Abstract][Full Text] [Related]
9. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
10. The Role of Cardioprotection in Cancer Therapy Cardiotoxicity:
Omland T; Heck SL; Gulati G
JACC CardioOncol; 2022 Mar; 4(1):19-37. PubMed ID: 35492815
[TBL] [Abstract][Full Text] [Related]
11. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
12. Getting the SCOOP-Survey of Cardiovascular Outcomes From Oncology Patients During Survivorship.
Bhatia N; Lenihan D; Sawyer DB; Lenneman CG
Am J Med Sci; 2016 Jun; 351(6):570-5. PubMed ID: 27238918
[TBL] [Abstract][Full Text] [Related]
13. Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies:
Parashar S; Akhter N; Paplomata E; Elgendy IY; Upadhyaya D; Scherrer-Crosbie M; Okwuosa TM; Sanghani RM; Chalas E; Lindley KJ; Dent S
JACC CardioOncol; 2023 Apr; 5(2):159-173. PubMed ID: 37144116
[TBL] [Abstract][Full Text] [Related]
14. Nutritional interventions for survivors of childhood cancer.
Cohen JE; Wakefield CE; Cohn RJ
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
[TBL] [Abstract][Full Text] [Related]
15. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
Gadzhanova S; Roughead EE; Bartlett LE
Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer:
Ioffe D; Bhatia-Patel SC; Gandhi S; Hamad EA; Dotan E
JACC CardioOncol; 2024 Apr; 6(2):143-158. PubMed ID: 38774000
[TBL] [Abstract][Full Text] [Related]
17. American Cancer Society prostate cancer survivorship care guidelines.
Skolarus TA; Wolf AM; Erb NL; Brooks DD; Rivers BM; Underwood W; Salner AL; Zelefsky MJ; Aragon-Ching JB; Slovin SF; Wittmann DA; Hoyt MA; Sinibaldi VJ; Chodak G; Pratt-Chapman ML; Cowens-Alvarado RL
CA Cancer J Clin; 2014; 64(4):225-49. PubMed ID: 24916760
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
